Abstract
The introduction of genetic engineering methods into the production of live influenza vaccines provides significant optimization of separate stages of this process. In recent years, special attention has been paid to a method based on the direct incorporation of well-known and well-studied mutations into the genome of epidemic variants of influenza virus. Such virus obtains the ts- and att phenotypes and can be used for the production of live influenza vaccines. The article discusses the applications of this approach and problems associated with its use in medical and veterinary vaccinology.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Aleksandrova, G.I. and Klimov, A.I., Zhivaya vaktsina protiv grippa (Living Vaccine against Influenza), St. Petersburg: Nauka, 1994.
Bhat, N., Wright, J., Broder, K., et al., Influenza-associated deaths among children in the United States, 2003–2004, N. Engl. J. Med., 2005, vol. 353, pp. 2559–2567.
Baudin, F., Petit, I., Weissenhorn, W., and Ruigrok, R., In vitro dissection of the membrane binding and RNP binding activities of influenza virus M1 protein, Virology, 2001, vol. 281, pp. 102–108.
Belshe, R., Mendelman, P., Treanor, J., et al., The efficacy of live attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine in children, N. Engl. J. Med., 1998, vol. 338, pp. 1405–1412.
Compans, R. and Klenk, H., Viral membranes, in Comprehensive Virology, Fraenkel-Conrat, H. and Wagner, R., Eds., New York: Plenum, 1979, vol. 13, pp. 293–407.
Cox, A. and Dewhurst, S., A single mutation at PB1 residue 319 dramatically increases the safety of PR8 live attenuated influenza vaccine in a murine model without compromising vaccine efficacy, J. Virol., 2015, vol. 90, no. 5, pp. 2702–2705.
Da Costa, B., Sausset, A., Munier, S., et al., Temperaturesensitive mutants in the influenza A virus RNA polymerase: alterations in the PA linker reduce nuclear targeting of the PB1-PA dimer and result in viral attenuation, J. Virol., 2015, vol. 89, no. 12, pp. 6376–6390.
Enami, M., Luytjes, W., Krystal, M., and Palese, P., Introduction of site-specific mutations into the genome of influenza virus, Proc. Natl. Acad. Sci. U.S.A., 1990, vol. 87, no. 10, pp. 3802–3805.
Ferko, B., Katinger, D., Grassauer, A., et al., Chimeric influenza virus replicating predominantly in the muriner upper respiratory tract induces local immune responses against human immunodeficiency virus type 1 in genital tract, J. Infect. Dis., 1998, vol. 178, pp. 1359–1368.
Ferko, B., Stasakova, J., Sereinig, S., et al., Hyperattenuated recombinant influenza A virus nonstructural-protein-encoding vectors induce human immunodeficiency virus type 1 Nef-specific systemic and mucosal immune responses in mice, J. Virol., 2001, vol. 75, pp. 8899–8908.
Fodor, E., Devenish, L., Engelhardt, O. G., et al., Rescue of influenza A virus from recombinant DNA, J. Virol., 1999, vol. 73, pp. 9679–9682.
Gendon, Yu.Z., Markushin, S.G., Tsfasman, T.M., et al., New cold-adapted strains–attenuation donors for living influenza vaccines, Vopr. Virusol., 2013, vol. 58, pp. 11–17.
Hickman, D., Hossain, J., Song, H., et al., An avian live attenuated master backbone for potential use in epidemic and pandemic influenza vaccines, J. Gen. Virol., 2008, vol. 89, pp. 2682–2690.
Hoffmann, E., Neumann, G., Hobom, G., et al., Ambisense approach for the generation of influenza A virus: vRNA and mRNA synthesis from one template, Virology, 2000b, vol. 267, no. 2, pp. 310–317.
Hoffmann, E., Neumann, G., Kawaoka, Y., et al., A DNA transfection system for generation of influenza A virus from eight plasmids, Proc. Natl. Acad. Sci. U.S.A., 2000a, vol. 97, no. 11, pp. 6108–6113.
Jang, Y., Byun, Y., Lee, K., et al., Host defense mechanism-based rational design of live vaccine, PLoS One, 2013, vol. 8, no. 10, pp. e75043–75054.
Jin, H., Lu, B., and Zhou, H., Multiple amino acid residues confer temperature sensitive to human influenza virus vaccine strains (FluMist) derived from cold-adapted A/Ann Arbor/6/60, Virology, 2003, vol. 306, pp. 18–24.
Jin, H., Zhou, H., Lu, B., et al., Imparting temperature sensitivity and attenuation in ferrets to A/Puerto Rico/8/34 influenza virus by transferring the genetic signature for temperature sensitivity from cold-adapted A/Ann Arbor/6/60, J. Virol., 2004, vol. 78, no. 2, pp. 995–998.
Kim, H.W., Arrobio, J.O., Brandt, C.D., et al., Temperature-sensitive mutants A virus: response of children to the influenza A/Hong Kong/68-ts-1(E)(H3N2) and influenza A/Udorn/72-ts-1(E)(H3N2) candidate vaccine viruses and significance of immunity to neuraminidase antigen, Pediatr. Res., 1976, vol. 10, pp. 238–242.
Kittel, C., Ferko, B., Kurz, M., et al., Generation of an influenza A virus vector expressing biologically active human interleukin-2 from the NS gene segment, J. Virol., 2005, vol. 79, pp. 10672–10677.
Kittel, C., Sereinig, S., Ferko, B., et al., Rescue of influenza virus expressing GFP from the NS1 reading frame, Virology, 2004, vol. 324, pp. 67–73.
Lamb, R.A., Zebedee, L.S., and Richardson, C.D., Influenza virus protein in an integral membrane protein expressed on the infected-cell surface, Cell, 1989, vol. 40, pp. 627–633.
Li, T. and Ye, Z., Introduction of a temperature-sensitive phenotype into influenza A/WSN/33 virus by altering the basic amino acid domain of influenza virus matrix protein, J. Virol., 2004, vol. 78, no. 18, pp. 9585–9591.
Luytjis, W., Krystal, M., Enami, M., et al., Amplification, expression and packaging of a foreign gene by influenza virus, Cell, 1989, vol. 59, pp. 1107–1113.
Maassab, H., Adaptation and growth characteristics of influenza virus at 25 degrees C, Nature, 1967, vol. 213, pp. 612–614.
Maassab, H.F. and Bryant, M.I., The development of live attenuated cold-adapted influenza virus vaccine for humans, Rev. Med. Virol., 1999, vol. 9, no. 4, pp. 237–244.
Markushin, S.G., Kost, V.Yu., Akopova, I.I., et al., The possible use of site-specific mutagenesis for construction of living influenza vaccines, Epidemiol. Vaktsinoprofil., 2014, no. 6, pp. 100–103.
Molinari, N., Ortega-Sanches, I., and Messonnier, M., The annual impact of seasonal influenza in the US: measuring disease burden and costs, Vaccine, 2007, vol. 25, pp. 5086–5096.
Murphy, B. and Coelingh, K., Principles underlying the development and use of live attenuated cold-adapted influenza A and B virus vaccines, Viral. Immunol., 2002, vol. 15, pp. 295–323.
Neumann, G., Watanabe, T., Ito, H., et al., Generation of influenza A viruses entirely from cloned cDNAs, Proc. Natl. Acad. Sci. U.S.A., 1999, vol. 96, no. 16, pp. 9345–9350.
Neumann, G., Zobel, A., and Hobom, G., RNA polymerase I-mediate expression of influenza viral RNA molecules, Virology, 1994, vol. 202, pp. 477–479.
Noton, S., Simpson-Holley, M., Medealf, E., et al., Studies of an influenza A virus temperature-sensitive mutant identify a late role for NP in the formation of infectious virions, J. Virol., 2009, vol. 83, no. 2, pp. 562–571.
Palese, P., Zheng, H., Engelhardt, O., et al., Negativestrand RNA viruses: genetic engineering and applications, Proc. Natl. Acad. Sci. U.S.A., 1996, vol. 93, no. 21, pp. 11354–11358.
Parkin, N., Chiu, P., and Coelingh, K., Genetically engineering live attenuated influenza A virus vaccine candidates, J. Virol., 1997, vol. 71, no. 4, pp. 2772–2778.
Pena, L., Vincent, A., Ye, J., et al., Modifications in the polymerase genes of a swine-like triple-reassortant influenza virus to generate live attenuated vaccines against 2009 pandemic H1N1 viruses, J. Virol., 2011, vol. 85, no. 1, pp. 456–469.
Porter, A.G., Smith, J.C., and Emtage, J.S., The sequence of influenza virus RNA segment 8 indicates that the coding regions for the NS1 and NS2 protein overlap, Proc. Natl. Acad. Sci. U.S.A., 1980, vol. 77, pp. 5074–5078.
Quinlivan, M., Zamarin, D., Garcia-Sastre, A., et al., Attenuation of equine influenza viruses through truncations of the NS1 protein, J. Virol., 2005, vol. 79, no. 13, pp. 8431–8439.
Richt, J., Lekcharoensuk, P., Lager, K., et al., Vaccination of pigs against swine influenza viruses by using an NS1-truncated modified live-virus vaccine, J. Virol., 2006, vol. 80, pp. 11009–11018.
Shah, N., Greenberg, J., McNulty, M., et al., Severe influenza in 33 US hospitals, 2013–2014: complications and risk factors for death in 507 patients, Infect. Contr. Hosp. Epidemiol., 2015, vol. 36, pp. 1251–1260.
Sereinig, S., Stukova, M., Zabolotnyh, N., et al., Influenza virus NS vectors expressing the Mycobacterium tuberculosis ESAT-6 protein induce CD4+Th1 immune response and protect animals against tuberculosis challenge, Clin. Vaccine Immunol., 2006, vol. 13, pp. 898–904.
Solorzano, A., Webby, R., Lager, K., et al., Mutations in the NS1 protein of swine influenza virus impair antiinterferon activity and confer attenuation in pigs, J. Virol., 2005, vol. 79, pp. 7535–7543.
Solorzano, A., Ye, J., and Perez, D.R., Alternative liveattenuated influenza vaccines based on modification in the polymerase genes protect against epidemic and pandemic flu, J. Virol., 2010, vol. 84, no. 9, pp. 4587–4596.
Song, H., Nieto, G., and Perez, D., A new generation of modified live-attenuated avian influenza viruses using a two-strategy combination as potential vaccine candidates, J. Virol., 2007, vol. 81, no. 17, pp. 9238–9248.
Steel, J., Loven, A., and Pena, L., Live attenuated influenza viruses containing NS1 truncations as vaccine candidates against H5N1 highly pathogenic avian influenza, J. Virol., 2008, vol. 83, no. 10, pp. 1742–1753.
Stukova, M., Sereinig, S., Zabolotnyh, N., et al., Vaccine potential of influenza vectors expressing Mycobacte rium tuberculosis ESAT-6 protein, Tuberculosis, 2006, vol. 86, pp. 236–246.
Subbarao, E. K., Kawaoka, Y., and Murphy, B.R., Rescue of an influenza A virus wild-type PB2 gene and a mutant derivative bearing a site-specific temperaturesensitive and attenuating mutation, J. Virol., 1993, vol. 67, no. 12, pp. 7223–7227.
Subbarao, K., Park, E., Lawson, C., et al., Sequential addition temperature-sensitive missense mutations into the PB2 gene of influenza A transfectant viruses can effect an increase in temperature sensitivity and attenuation and permits the rational design of a genetically engineered live influenza A virus vaccine, J. Virol., 1995, vol. 69, no. 10, pp. 5969–5977.
Tabynov, K., Sansyzbay, A., Kydyrbayev, Z., et al., Influenza viral vectors expressing the Brucella OMP16 or L7/L12 proteins as vaccines against B. abortus infection, J. Virol., 2014, vol. 11, p. 69.
Talon, J., Salvatore, M., O’Neill, R., et al., Influenza A and B viruses expressing altered NS1 proteins: a vaccine approach, Proc. Natl. Acad. Sci. U.S.A., 2000, vol. 97, pp. 4309–4314.
Terekhov, A.V., Tsfasman, T.M., Markushin, S.G., et al., Genetic bases of attenuation of cold-adapted strain A(H2N2)/Krasnodar/101/35/59—donor for living influenza vaccines, Epidemiol. Vaktsinoprofil., 2013, no. 3, pp. 70–77.
Tolpin, M.D., Massicot, J.G., Mullinix, M.G., et al., Genetic factors associated with loss of the temperaturesensitive phenotype of the influenza A/Alaska/77-ts-1 A2 recombinant during growth in vivo, Virology, 1981, vol. 112, pp. 505–512.
Vincent, A., Ma, W., Lager, K., et al., Efficacy of intranasal administration of a truncated NS1 modified live influenza virus vaccine in swine, Vaccine, 2007, vol. 25, pp. 7990–8009.
Wacheck, V., Egorov, A., Groiss, F., et al., A novel type of influenza vaccine: safety and immunogenicity of replication-deficient influenza virus created by deletion of the interferon antagonist NS1, J. Infect. Dis., 2010, vol. 201, pp. 354–362.
Zhou, B., Li, Y., Speer, S., et al., Engineering temperature sensitive live attenuated influenza vaccines from emerging viruses, Vaccine, 2012, vol. 30, no. 24, pp. 3691–3702.
Author information
Authors and Affiliations
Corresponding author
Additional information
Original Russian Text © S.G. Markushin, A.A. Rtishchev, 2016, published in Uspekhi Sovremennoi Biologii, 2016, Vol. 136, No. 6, pp. 568–579.
Rights and permissions
About this article
Cite this article
Markushin, S.G., Rtishchev, A.A. Creation of live influenza vaccines with the use of site-specific mutagenesis. Biol Bull Rev 7, 323–332 (2017). https://doi.org/10.1134/S2079086417040065
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S2079086417040065